1. Home
  2. PCRX vs HBNC Comparison

PCRX vs HBNC Comparison

Compare PCRX & HBNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PCRX
  • HBNC
  • Stock Information
  • Founded
  • PCRX 2006
  • HBNC 1873
  • Country
  • PCRX United States
  • HBNC United States
  • Employees
  • PCRX N/A
  • HBNC N/A
  • Industry
  • PCRX Biotechnology: Pharmaceutical Preparations
  • HBNC Major Banks
  • Sector
  • PCRX Health Care
  • HBNC Finance
  • Exchange
  • PCRX Nasdaq
  • HBNC Nasdaq
  • Market Cap
  • PCRX 604.7M
  • HBNC 648.7M
  • IPO Year
  • PCRX 2011
  • HBNC N/A
  • Fundamental
  • Price
  • PCRX $16.52
  • HBNC $18.29
  • Analyst Decision
  • PCRX Buy
  • HBNC Hold
  • Analyst Count
  • PCRX 10
  • HBNC 3
  • Target Price
  • PCRX $26.60
  • HBNC $15.33
  • AVG Volume (30 Days)
  • PCRX 545.3K
  • HBNC 173.4K
  • Earning Date
  • PCRX 11-06-2024
  • HBNC 10-23-2024
  • Dividend Yield
  • PCRX N/A
  • HBNC 3.50%
  • EPS Growth
  • PCRX N/A
  • HBNC N/A
  • EPS
  • PCRX N/A
  • HBNC 0.48
  • Revenue
  • PCRX $694,957,000.00
  • HBNC $183,718,000.00
  • Revenue This Year
  • PCRX $4.59
  • HBNC N/A
  • Revenue Next Year
  • PCRX N/A
  • HBNC $13.00
  • P/E Ratio
  • PCRX N/A
  • HBNC $37.83
  • Revenue Growth
  • PCRX 4.40
  • HBNC N/A
  • 52 Week Low
  • PCRX $11.16
  • HBNC $10.65
  • 52 Week High
  • PCRX $35.95
  • HBNC $18.86
  • Technical
  • Relative Strength Index (RSI)
  • PCRX 44.28
  • HBNC 69.60
  • Support Level
  • PCRX $16.11
  • HBNC $18.30
  • Resistance Level
  • PCRX $18.34
  • HBNC $18.86
  • Average True Range (ATR)
  • PCRX 0.83
  • HBNC 0.49
  • MACD
  • PCRX -0.17
  • HBNC 0.19
  • Stochastic Oscillator
  • PCRX 5.33
  • HBNC 91.11

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has three commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve.

About HBNC Horizon Bancorp Inc.

Horizon Bancorp (IN) is a United States-based holding company providing banking services. It is engaged in providing commercial and retail banking services, corporate and individual trust and agency services, and other services incident to banking. The company also provides commercial loans, real estate loans, mortgage warehouse loans, consumer loans, and other credit facilities. The company has one principal business segment, commercial banking.

Share on Social Networks: